Petros Pharmaceuticals, Inc.
PTPI
$0.0849
-$0.007-7.62%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 62.79% | 67.90% | 57.92% | 59.26% | 47.08% |
| Total Depreciation and Amortization | -11.08% | -23.39% | -32.03% | -38.55% | -43.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -584.63% | -185.05% | -162.50% | -178.03% | -64.62% |
| Change in Net Operating Assets | 839.60% | -71.77% | 646.98% | 120.22% | 106.35% |
| Cash from Operations | 15.98% | -96.09% | 3.11% | 40.40% | 64.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 10.61% | 11.47% | -2.23% | 9.87% | 59.91% |
| Issuance of Common Stock | 0.00% | -- | -- | -- | -41.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -159.95% | 823.81% | 1,095.81% | 810.38% | -39.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -307.35% | 101.27% | 129.52% | 127.12% | 122.82% |
